Health Ministry Warns of Slimming Product After Young Man Hospitalized
Translated & summarized from i24NEWS by baba
Israel's Ministry of Health is warning the public about the weight-loss product "G-Slim" after a young man was hospitalized due to its consumption. Lab tests found the product contains a banned pharmaceutical ingredient, Sibutramine, in dangerously high amounts.
The story in 4 lines · by baba
- Health Ministry warns against "G-Slim" weight-loss product.
- Young man hospitalized after consuming the supplement.
- Product contains banned Sibutramine in high concentrations.
- Sibutramine poses severe health risks, including heart attack and stroke.
Israel's Ministry of Health issued a public warning on Tuesday against purchasing and consuming the product "G-Slim," marketed as a weight-loss supplement. The warning comes after a young man was recently hospitalized suffering from chest pains and a rapid heartbeat after using the product.
Laboratory tests revealed that G-Slim contains Sibutramine, a pharmaceutical ingredient banned in Israel and many other countries due to significant health risks. The ministry noted that no registered products in Israel contain this substance. The tests found 53.8 mg of Sibutramine per capsule, more than triple the amount found in a similar product previously outlawed.
Consuming products with Sibutramine without medical supervision can lead to severe side effects, including increased blood pressure, rapid pulse, anxiety, insomnia, heart attack, stroke, psychiatric disorders, and even death. The ministry emphasized that the risk is potentially higher due to the unusually large quantity of Sibutramine found in G-Slim.
The same event, reported separately by each outlet. Open a few to compare what different newsrooms emphasize — and what they leave out.
Centre 7Right 5Haredi 2Arab 1Other 5
Not the same event — other stories that share this one’s people, places, or theme: background, reactions, and follow-ups.